Vivo Capital
Founded in 1996, Vivo Capital is a global investment firm focused on healthcare. With approximately $5.8 billion in assets under management and investments in over 290 public and private companies worldwide, the firm operates from Palo Alto, California, with additional offices in Asia. Its team comprises 50 multidisciplinary professionals, including physicians, scientists, entrepreneurs, operating executives, and industry experts. Vivo Capital invests across various healthcare sectors such as biotechnology, pharmaceuticals, medical devices, and healthcare services.
Top Sectors
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Lyon
Avadel Pharmaceuticals
Post in 2020
Avadel Pharmaceuticals is a specialty pharmaceutical company focused on developing and marketing differentiated drug products. It operates internationally with headquarters in Dublin and a presence in St. Louis and Lyon. The portfolio centers on urology, central nervous system/sleep, and hospital products, including LUMRYZ, an extended-release formulation of sodium oxybate for narcolepsy-related cataplexy and excessive daytime sleepiness in adults. The company markets three sterile injectable medicines for hospital use: Akovaz for hypotension during anesthesia, Bloxiverz for reversal of non-depolarizing neuromuscular blocking agents after surgery, and Vazculep for treatment of hypotension. Avadel pursues new product development through formulation innovation and partnerships to improve patient adherence and outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.